Compare

FOXO4-DRI vs PEG-MGF

Side-by-side observational reports from PeptIQ users. This compares self-reported patterns — not clinical head-to-head trials.

Last reviewed . By the PeptIQ team.

Observational reporting only — not medical advice. Does not recommend doses, protocols, or treatments.

FOXO4-DRI

722 community reports

Overall experience

From check-in ratings — separate from side effects logged below. Side effects are logged separately from overall experience. A favorable check-in can still include nausea, fatigue, or injection-site reactions.

Favorable 56% · Mixed 34% · Unfavorable overall 10%

Most reported benefits

Benefits users selected when logging a favorable or mixed check-in.

Appetite control
-151
Energy
-31
Mood
-16
Focus
8
Sleep quality
11

Most logged side effects

Side effects are logged separately from overall experience. A favorable check-in can still include nausea, fatigue, or injection-site reactions.

GI discomfort
-55
Dizziness
-132
Fatigue
-51
Nausea
4
Water retention
11

Self-reported dose per injection

Median bucket: 0.4–0.6 mg · Most common: 0.4–0.6 mg

Reports span 0.1–2 mg

0.1–0.2 mg
6
0.2–0.4 mg
15
0.4–0.6 mg
23
0.6–1 mg
16
1–2 mg
9

Anonymized self-reports from PeptIQ users — not prescribing guidance. Buckets group similar logged amounts; open-ended top buckets mean “at least” that dose.

Common discussion topics

timing46stacking24side effects22foxo4-dri30

How repeat users are trending

Among repeat reporters, 66% said they felt similar to their last entry, 30% more positive, and 16% more negative.

Overall, repeat reporters leaned more positive than their previous entry.

Median gap between entries: 28 days · Based on 159 repeat reporters

PEG-MGF

865 community reports

Overall experience

From check-in ratings — separate from side effects logged below. Side effects are logged separately from overall experience. A favorable check-in can still include nausea, fatigue, or injection-site reactions.

Favorable 49% · Mixed 42% · Unfavorable overall 9%

Most reported benefits

Benefits users selected when logging a favorable or mixed check-in.

Focus
-20
Sleep quality
-37
Lean mass
-107
Joint comfort
-116
Recovery
-72

Most logged side effects

Side effects are logged separately from overall experience. A favorable check-in can still include nausea, fatigue, or injection-site reactions.

Nausea
-104
Water retention
-138
Appetite loss
-142
Injection site reaction
-120
Anxiety
-72

Self-reported dose per injection

Median bucket: 200–400 mcg · Most common: 200–400 mcg

Reports span 50–1000 mcg

50–100
3
100–200
9
200–400
24
400–600
12
600–1000
3

Anonymized self-reports from PeptIQ users — not prescribing guidance. Buckets group similar logged amounts; open-ended top buckets mean “at least” that dose.

Common discussion topics

timing29stacking12side effects15peg-mgf23

How repeat users are trending

Among repeat reporters, 59% said they felt similar to their last entry, 41% more positive, and 19% more negative.

Overall, repeat reporters leaned more positive than their previous entry.

Median gap between entries: 30 days · Based on 190 repeat reporters

Sources (4)

Published sources linked on the FOXO4-DRI and PEG-MGF wiki pages.

  1. PubMed

    Targeted Apoptosis of Senescent Cells Restores Tissue Homeostasis in Response to Chemotoxicity and Aging (FOXO4-DRI)

    Baar MP, Brandt RMC, Putavet DA, et al. Cell. 2017

    Source
    Wiki study page →
  2. PubMed

    Eliminating Senescent Cells Can Promote Pulmonary Hypertension Development and Progression

    Born E, Lipskaia L, Breau M, et al. Circulation. 2023

    Source
    Wiki study page →
  3. PubMed

    Targeted Apoptosis of Senescent Cells Restores Tissue Homeostasis in Response to Chemotoxicity and Aging

    Baar MP, Brandt RMC, Putavet DA, et al. Cell. 2017

    Source
    Wiki study page →
  4. PubMed

    Mechano growth factor E peptide (MGF-E), a muscle-specific splice variant of IGF-1

    Yang SY, Goldspink G. Biochem Biophys Res Commun. 2004

    Source
    Wiki study page →